Key Takeaways
- Strong headline growth, margin reset: Revenue rose 71.5% YoY to ₹291.8 crore, but EBITDA margin fell 571 bps to 8.1% as a one-off prior-year gain unwound and a low-margin revenue mix hit the quarter.
- The margin drop is a point-in-time event: Half the decline came from an unrepeatable purchase price variance gain in Q2 FY23, the other half from a revenue mix skewed toward a low-margin account that management says will not recur in H2.
- Aerospace and defense is the growth engine: The segment is the fastest-growing part of the business, two new large multinational logos were added in the quarter, and management expects to announce new programs soon.
- Investing ahead of the curve: SG&A rose on planned go-to-market, leadership and capability builds; management is explicit it will not hesitate to invest in growth even if it means trading off near-term margin.
- What to watch next quarter: Whether the promised H2 margin recovery materializes as the adverse revenue mix reverses, the pace of order book conversion from a pipeline management calls roughly a billion dollars, and any disruption from the Israel-Hamas conflict given the company's Israeli customer and supply-chain exposure.
Revenue & Margin Mechanics
- YoY revenue jump: The 71.5% growth was driven largely by aerospace and defense, with the company continuing to benefit from strong demand in those end markets.
- EBITDA margin walk: The 571 bps YoY decline to 8.1% breaks into two roughly equal halves: a one-off purchase price variance gain in Q2 FY23 that did not repeat, and an adverse revenue mix where a low-margin account contributed almost twice the revenue it did a year ago.
- PPV explained: Last year's supply chain constraints forced procurement at elevated costs; customer recoveries landed in Q2 FY23 at an unusually high level. The current quarter's PPV is at normal levels because supply chains have stabilized.
- Mix is temporary: Management characterized the Q2 revenue mix as "very unique to this quarter" and stated the same mix is not expected in H2.
- PAT aided by other income: PAT of ₹14.7 crore grew 106.4% YoY, helped by gains from investment of IPO proceeds.
- No destocking signal: The company is not seeing a slowdown in its sectors; inventory lead times are coming down and long-lead material bought during supply shortages is now being consumed, which management calls "equalizing" rather than a genuine slowdown.
Management: "I would call it more of an equalizing of how the supply is getting consumed as opposed to it genuinely being a slowdown. At least that's how it relates to the sectors we're in and the clients that we're engaged with."
Segment & Client Dynamics
| Segment | Trend | Commentary |
|---|---|---|
| Aerospace & Defense | ▲ Fastest growth | Two new large multinational logos added; new program announcements expected in coming quarters. |
| Medical Technology | ▼ Declined | Decline driven by a single local client whose COVID-testing device demand dropped; medical broadly remains a growth area and a key organic and inorganic priority. |
| Industrial | ▲ Growing pipeline | More deals seen in industrial and medtech; both expected to represent a higher mix going forward. |
| Exports | ▬ ~60% of revenue | Down from 70% last quarter; expected to stay in that ballpark. |
- Logo addition strategy: The business model favors a few high-potential logos per quarter rather than high-volume churn; two logos per quarter creates "tremendous potential."
- Supply chain localization: A significant trend and ask from suppliers to localize; management calls it a key strategy.
- Israel-Hamas exposure: The company has Israeli customers and supply-chain dependencies. Direct feedback from suppliers has been business as usual, but management is setting expectations that disruptions could occur.
Anthony Montalbano: "For us, a couple key logos like this, a quarter, creates tremendous potential for us. So, our business is different as opposed to having to add 8 logos, 9 logos, 10 logos that might be more in line with a higher volume business where there's more churn in that regard."
Capability Builds & Expansion
- Bangalore facility: A new facility is being inaugurated in December.
- Mysore cable harness expansion: Capacity is being expanded at the Mysore facility; management says it is in very advanced stages and will be sufficient to grow the cable harness business 10x from current levels.
- Cable harness demand: Several opportunities in the pipeline; customers are reaching out demanding higher work, and the company needs higher realistic capacity to cater to requirements.
- Build-to-spec ambition: Management expects build-to-spec to reach roughly 15% of revenue in three years and maybe 20% in five years; these programs carry margins two to three points higher than build-to-print.
- Design as differentiator: Cyient DLM can bring the CEO of Cyient Engineering into client meetings to offer integrated design-through-manufacturing solutions, a capability management says even very large EMS companies cannot match at this scale.
Management: "even very large EMS companies would not have anywhere close to this scale of design capability. And so, we are in a unique position where we can go to clients and sit at the table and really provide true design through manufacturing offering."
Order Book & Pipeline
- Order backlog expected to rise: Several large deals are in the pipeline; management expects the order book to inch up as deals convert.
- Pipeline size: Management described the pipeline as roughly a billion dollars but declined to give a specific number.
- Conversion confidence: The company believes it will run in the higher bounds of conversion rates (30-40%) because of the type of work it provides. [15-16]
- Order inflow pacing: The attempt is to keep order inflow pace aligned with revenue growth.
- Inorganic strategy: Inorganic opportunities are a key part of strategy, prioritized around capability and footprint; discussions are underway with several opportunities.
Working Capital & Balance Sheet
- Receivables improvement: Receivables coming down is positive.
- Payables pressure: Payables have declined because raw materials are in high demand and vendors have stopped extending credit, asking for advance payment instead. [11-12]
- Networking capital target: Intention is to hold networking capital days between 90 and 100 by the end of FY24.
- Free cash flow: On a full-year basis, management expects free cash flow to be moderately positive.
- IPO proceeds: Utilized only for repaying an external loan as stated in the RHP and for working capital.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| H2 revenue split | 55% of full-year revenue in H2, continuing the 45/55 H1/H2 pattern | FY24 |
| Revenue mix normalization | The low-margin-heavy mix seen in Q2 is not expected to repeat | H2 FY24 |
| Networking capital days | Hold between 90 and 100 days | By end FY24 |
| Free cash flow | Moderately positive on a full-year basis | FY24 |
| Build-to-spec revenue share | ~15% of revenue | In three years |
| Build-to-spec revenue share | ~20% of revenue | In five years |
| Cable harness capacity | Expand Mysore facility to support 10x growth from current levels | No date (advanced stages) |
| Order backlog | Expected to inch up as pipeline deals convert | No date |
| Double-digit EBITDA margin | Goal is to be close to double-digit margins; may provide further update as year progresses and costs come out [10-11] | No date (directional) |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Revenue | ₹291.8 cr, +71.5% YoY |
| H1 FY24 revenue | ₹509 cr, +49.6% YoY |
| EBITDA | ₹23.5 cr, margin at 8.1%, down 571 bps YoY |
| Profit after tax | ₹14.7 cr, +106.4% YoY, aided by other income |
| Order book | ₹2,287 cr as of Sep 2023, reduced marginally QoQ |
| Order backlog | ~₹2,300 cr |
| Year-to-date order intake | ₹4.19 cr |
| Order pipeline | ~$1 bn, can move a couple hundred million either way |
| Aerospace & defense revenue share | ~70% of business |
| Export revenue share | 58% in Q2, domestic 42% |
| PCBA revenue share | ~70% of overall revenue; box build ~20% plus or minus 5% |
| Inventory days | 144 days, reduced from prior periods |
| Net working capital | 111 days in the quarter |
| Free cash flow | Negative for Q2 and H1; full year expected moderately positive |
| Forex loss | ~0.5% of Q2 revenue |